ONCONANO MEDICINE, INC.

Profile

Company Names

ONCONANO MEDICINE, INC.

Addresses

3060 PEGASUS PARK DRIVE, DALLAS, TX 75247

181 GRAND AVENUE, SUITE 225, SOUTHLAKE, TX 76092

181 GRAND AVENUE, SUITE 225, SOUTHLAKE, TX 76092

550 RESERVE STREET, SUITE 190, SOUTHLAKE, TX 76092

5323 HARRY HINES BLVD., DALLAS, TX 75390

Phone Numbers

682-285-1411
(682) 285-1411
682.285.1411
(408) 476-1904
(682) 712-1581

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2014

State Incorporated:

DELAWARE

Total Amount Raised:

$115,004,891.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2025-04-11 
$12,698,061.00 
$12,698,061.00 
$0.00 
Equity 
2
2020-10-15 
$68,407,469.00 
$68,407,469.00 
$0.00 
Equity 
1
2018-03-13 
$33,899,361.00 
$35,392,140.00 
$1,492,779.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
PARITOSH 
 
DHAWALE 
DIRECTOR
ONCONANO MEDICINE, INC.
MARTIN 
 
DRISCOLL 
EXECUTIVE OFFICER, DIRECTOR
ASMACURE, INC.   |  SPRING BANK PHARMACEUTICALS, INC.   |  ONCONANO MEDICINE, INC.
JOHN 
 
DYETT 
DIRECTOR
SALEM ZS INVESTORS, LLC   |  SALEM FEMASYS INVESTORS LLC   |  FEMASYS INC   |  SEBACIA, INC.   |  SALEM SEBACIA INVESTORS, LLC   |  SALEM ONCONANO INVESTORS, LLC   |  ONCONANO MEDICINE, INC.   |  CORONADO AESTHETICS, LLC   |  SALEM ONM INVESTORS 2025 LLC
BRETT 
 
GIROIR 
DIRECTOR
REVELAR BIOTHERAPEUTICS, INC.   |  ALTESA BIOSCIENCES, INC.   |  ONCONANO MEDICINE, INC.
JOYDEEP 
 
GOSWAMI 
DIRECTOR
ONCONANO MEDICINE, INC.   |  BIOLIFE SOLUTIONS INC
ALVARO 
 
GUILLEM 
DIRECTOR, EXECUTIVE OFFICER
ONCONANO MEDICINE, INC.   |  RENIBUS THERAPEUTICS, INC.   |  NANOSCOPE THERAPEUTICS, INC.
MATTHEW 
 
HEAD 
EXECUTIVE OFFICER
ONCONANO MEDICINE, INC.
GINA 
 
JONES 
DIRECTOR
SOUTHERN SILVER EXPLORATION CORP   |  ONCONANO MEDICINE, INC.
JEFF 
 
KEYSER 
EXECUTIVE OFFICER
ONCONANO MEDICINE, INC.   |  CX PRECISION MEDICINE, INC.   |  CAGE BIO, INC.
KARTIK 
 
KRISHNAN 
EXECUTIVE OFFICER, DIRECTOR
ONCONANO MEDICINE, INC.
MELISSA 
 
PAOLONI 
EXECUTIVE OFFICER
ONCONANO MEDICINE, INC.
YUMIN 
 
QIU 
DIRECTOR
ONCONANO MEDICINE, INC.
YUMIN 
 
QUI 
DIRECTOR
ONCONANO MEDICINE, INC.
CALEB 
 
SMITH 
DIRECTOR
ONCONANO MEDICINE, INC.   |  HUBBELL REALTY CO   |  SALEM ONM INVESTORS 2025 LLC
RAVI 
 
SRINIVASAN 
EXECUTIVE OFFICER, DIRECTOR
ONCONANO MEDICINE, INC.   |  I2O THERAPEUTICS, INC.   |  CAGE BIO, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2025-06-02
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-04-11 
2021-11-03
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-10-15 
2021-06-17
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-10-15 
2021-03-26
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-10-15 
2020-10-21
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-10-15 
2019-04-22
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-03-13 
2018-03-28
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-03-13 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
SALEM PARTNERS LLC
43363